US Foods to Present at the BMO Global Farm to Market Conference
ROSEMONT, Ill.–(BUSINESS WIRE)–US Foods Holding Corp. (NYSE: USFD) announced today that Dave Flitman, Chief Executive Officer, and Dirk Locascio, Chief... Read more.
Krispy Kreme Board Nominates Refreshed Slate of Directors to Support Company’s Transformation
Bernardo Hees, Seasoned Executive in Food Retail and Consumer Goods, Nominated to Join Board of Directors and Chair Strategy & Operating Committee CHARLOTTE,... Read more.
Portable Medical Devices Market Overview 2024: Rising Emphasis on Home Healthcare Solutions, Fueled by Aging Populations and Demographic Shifts – Global Forecast to 2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Portable Medical Devices Market – Products and Applications” report has been added to ResearchAndMarkets.com’s... Read more.
Linde Named One of Ethisphere’s 2025 World’s Most Ethical Companies®
WOKING, England–(BUSINESS WIRE)–Linde (Nasdaq: LIN) today announced it has been included in the 2025 World’s Most Ethical Companies® list for... Read more.
Wabtec Reports First Quarter 2025 Results; Announces Increase in Full-Year EPS Guidance
GAAP Diluted Earnings Per Share of $1.88, Up 22.9%; Adjusted Diluted Earnings Per Share of $2.28, Up 20.6% GAAP Operating Margin at 18.2%; Adjusted Operating Margin... Read more.
Central Pacific Financial Reports First Quarter 2025 Earnings of $17.8 Million
Highlights include: Net income of $17.8 million, or $0.65 per diluted share Return on average assets of 0.96% and return on average equity of 13.04% Efficiency ratio... Read more.
REPLY S.p.A.: Shareholders’ Meeting Approves the 2024 Financial Statements
Consolidated turnover of €2,295.9 million (€2,118.0 million in 2023); Group net profits of €211.1 million (€186.7 million in 2023) The proposal to distribute... Read more.
Aurion Biotech Appoints Edward J. Holland, M.D., as Chief Medical Officer and Eris P. Jordan, O.D., as Chief Development Officer
Key leadership appointments to accelerate global clinical development of AURN001, a transformational cell therapy for corneal endothelial disease SEATTLE & CAMBRIDGE,... Read more.
Summit Bank Group Reports 2025 1st Quarter Earnings
EUGENE, Ore.–(BUSINESS WIRE)–Summit Bank Group (OTC Pink: SBKO) Q1 2025 Net Income of $2.93 million or $0.37 per fully diluted share; an increase of... Read more.
Desired Effect Launches First Vuln/Exploit Ethical Market – Brings Defenders to the Pre-Attack Buying Pool, Strips Attackers of Cheap Exploits and First-Mover Edge
Defenders Gain True Pre-Attack Intel, Independent Researchers Gain Greater Rewards, Recognition. SAN FRANCISCO & BALTIMORE–(BUSINESS WIRE)–#DesiredEffect—Desired... Read more.